Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecile Magis-Escurra

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The European Respiratory Journal|November 9, 2016
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the uglyRichard van Altena, Onno W Akkerman, Jan-Willem C Alffenaar, et al.
International Journal of Antimicrobial Agents|May 12, 2018
Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in childrenLisa C Martial, Jordy Kerkhoff, Nilza Martinez, et al.
Therapeutic Drug Monitoring|June 7, 2019
Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 CountriesMarlanka A Zuur, Herman Veenhof, Alena Aleksa, et al.
American Journal of Respiratory and Critical Care Medicine|August 18, 2015
A Step toward an Optimized Rifampin Dose CompletedMartin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2015
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosisMartin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
American Journal of Respiratory and Critical Care Medicine|March 7, 2018
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European CountriesGunar Günther, Frank van Leth, Sofia Alexandru, et al.
The New England Journal of Medicine|September 15, 2016
Treatment Outcomes in Multidrug-Resistant TuberculosisGunar Günther, Christoph Lange, Sofia Alexandru, et al.
The European Respiratory Journal|June 10, 2017
Treatment outcomes of MDR-TB and HIV co-infection in EuropeCecile Magis-Escurra, Gunar Günther, Christoph Lange, et al.
Emerging Infectious Diseases|February 20, 2015
Multidrug-resistant tuberculosis in Europe, 2010-2011Gunar Günther, Frank van Leth, Sofia Alexandru, et al.
Journal of Clinical Pharmacology|September 23, 2021
Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic ModelingCarlijn H C Litjens, Laurens F M Verscheijden, Celine Bolwerk, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The European Respiratory Journal|November 9, 2016
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the uglyRichard van Altena, Onno W Akkerman, Jan-Willem C Alffenaar, et al.
International Journal of Antimicrobial Agents|May 12, 2018
Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in childrenLisa C Martial, Jordy Kerkhoff, Nilza Martinez, et al.
Therapeutic Drug Monitoring|June 7, 2019
Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 CountriesMarlanka A Zuur, Herman Veenhof, Alena Aleksa, et al.
American Journal of Respiratory and Critical Care Medicine|August 18, 2015
A Step toward an Optimized Rifampin Dose CompletedMartin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2015
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosisMartin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
American Journal of Respiratory and Critical Care Medicine|March 7, 2018
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European CountriesGunar Günther, Frank van Leth, Sofia Alexandru, et al.
The New England Journal of Medicine|September 15, 2016
Treatment Outcomes in Multidrug-Resistant TuberculosisGunar Günther, Christoph Lange, Sofia Alexandru, et al.
The European Respiratory Journal|June 10, 2017
Treatment outcomes of MDR-TB and HIV co-infection in EuropeCecile Magis-Escurra, Gunar Günther, Christoph Lange, et al.
Emerging Infectious Diseases|February 20, 2015
Multidrug-resistant tuberculosis in Europe, 2010-2011Gunar Günther, Frank van Leth, Sofia Alexandru, et al.
Journal of Clinical Pharmacology|September 23, 2021
Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic ModelingCarlijn H C Litjens, Laurens F M Verscheijden, Celine Bolwerk, et al.
Pageof 6